Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Six Finance Senators Strive For Bipartisan Compromise
As the public face of health reform devolves into a partisan fight - with one GOP Senator [Jim DeMint, S.C.] saying the reform push is President Obama"s "Waterloo," and Democrats retorting that Republicans would derail the overhaul for political gain - a group of legislators in the Senate Finance Committee has continued to strive for a compromise behind closed doors, the Christian Science Monitor reports. "If a bipartisan compromise is to clear Congress this year, its main lines are likely to emerge here."

Pneumonic Plague Kills Third Human In Chinese Town
Authorities in China confirmed that a third man has died of pneumonic plague in Ziketan, Qinghai Province, China. The town has been sealed off. The 64-year-old man lived near the other two men who died, officials said.
News of the day
UNMC Scientists ID Molecule Superfamily That Causes Melanoma Spread
A University of Nebraska Medical Center research team has determined that a superfamily of molecules hold the secret to the progression and spread of melanoma -- the deadliest form of skin cancer. The study results were published in today"s issue of the British Journal of Cancer.
Diagnostics

Data Presented At The 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected In HIV-Positive Men

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that new data from the two-part HYHYHI Study (Hypogonadal Hypotestosteronism in HIV-Seropositive Men) were presented as a poster today at the 5th International AIDS Society (IAS) Conference in Cape Town, South Africa. This retrospective chart review, supported by the Company, evaluated the challenges associated with diagnosing low testosterone in men with HIV/AIDS. The study also compared the difference in testosterone levels achieved after 12 months of treatment with either Testim® 1% (testosterone gel) or AndroGel®, two commonly used FDA-approved testosterone replacement products. Results from the study showed that when using the more sensitive Free Testosterone test (FT About the Study The HYHYHI study, designed and conducted by Dr. Blick, was a retrospective chart review of men with HIV/AIDS screened for Low T and treated with testosterone replacement therapy. Data were collected from two U.S. sites and included 400 men diagnosed with HIV/AIDS and screened for Low T, defined as Total T About Testim Testim is a proprietary, clear, topical gel containing 1% testosterone, the same type of hormone that is produced by the human body. When applied once-daily to the upper arms and shoulders, clinical studies have shown that Testim will restore and maintain testosterone levels. Once Testim is absorbed through the skin, it enters the bloodstream and helps return testosterone to normal levels. The efficacy of Testim has been demonstrated in 16 clinical studies involving approximately 1,800 patients, including the largest placebo-controlled study ever conducted to evaluate the benefits and risks of testosterone replacement therapy. Auxilium estimates that approximately 76 million tubes, or daily applications, of Testim have been used since the product was launched in 2003. For information regarding the safety and use of Testim, please see the prescribing information at http://www.testim.com. Auxilium Pharmaceuticals, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009